NASDAQ · Financial Statements
BIOLASE, Inc. (BIOL) Financial Statements
$0.02
NASDAQ: BIOL
Market Cap $731942
Overview Financials Dividend BIOLASE, Inc. most recently reported annual revenue of $49.0M, net profit of $-21.0M, revenue has compounded at 1.3% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2019 2020 2021 2022 2023 Revenue $38.0M $23.0M $39.0M $48.0M $49.0M Operating Profit $-16.0M $-19.0M $-16.0M $-25.0M $-18.0M Net Profit $-18.0M $-17.0M $-16.0M $-29.0M $-21.0M EPS $-1923.95 $-688.19 $-273.41 $-413.19 $-16.14 Op Margin -41.3% -81.4% -41.1% -52.3% -36.5%
Balance Sheet (USD)
Metric 2019 2020 2021 2022 2023 Total Assets $32.0M $41.0M $55.0M $38.0M $35.0M Total Liabilities $31.0M $31.0M $30.0M $33.0M $35.0M Cash $6.0M $18.0M $30.0M $4.0M $7.0M Borrowings $14.0M $18.0M $15.0M $16.0M $18.0M
Cash Flow (USD)
Metric 2019 2020 2021 2022 2023 Operating Cash Flow $-13.0M $-13.0M $-17.0M $-27.0M $-14.0M Investing Cash Flow $0 $0 $-1.0M $-11.0M $-2.0M Financing Cash Flow $-1.0M $12.0M $16.0M $0 $3.0M Net Cash Flow $-2.0M $12.0M $12.0M $-26.0M $2.0M Free Cash Flow $-13.0M $-13.0M $-17.0M $-30.0M $-15.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -0.78 FCF Yield -2104.27% Quick Ratio 0.68 Interest Coverage -7.60 Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock